Trial Profile
Effect of Vedolizumab on healthcare resource utilization in biologic-naive Inflammatory Bowel Disease (IBD) Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jan 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 17 Jan 2018 New trial record